Tonghua Dongbao reveals top shareholders before share repurchase

Tonghua Dongbao Pharmaceutical Co., Ltd. announced the shareholding details of its top ten shareholders as of October 17, 2025. This date was one trading day before the board's resolution on its share repurchase plan, which was approved on October 17, 2025, and involves repurchasing company shares through centralized bidding.

East Treasure Industrial Group Co., Ltd. remains the largest shareholder, holding 613,823,496 shares, representing 31.34% of the company's total share capital. Tianjin Zhenyi Equity Investment Partnership (Limited Partnership) is the second-largest, with 183,058,967 shares (9.35%). Hong Kong Securities Clearing Company Limited holds 36,244,430 shares (1.85%), while the Abu Dhabi Investment Authority holds 33,189,712 shares (1.69%).

Other significant shareholders include China Merchants CSI Biomedical Index Graded Securities Investment Fund managed by Bank of China (17,131,777 shares, 0.87%) and CSI 500 Transactional Open-ended Index Securities Investment Fund managed by Agricultural Bank of China (16,715,007 shares, 0.85%). The company confirmed that all its shares are unrestricted circulating shares, meaning the top ten shareholders are identical to the top ten unrestricted shareholders.